EBV TCR-T: Clinical Trials

1 trial of EBV TCR-T, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow EBV TCR-T: new trials by email Literature Review of EBV TCR-T trials Research Report on EBV TCR-T

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
EBV TCR-T - NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL)
Early Phase 1RecruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine242025-09-202025-12-02

Conditions studied

Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Results publications

PMID 18042692, PMID 19880495, PMID 20671118, PMID 23023715, PMID 23649469, PMID 24142051, PMID 26202875, PMID 26222726, PMID 26353084, PMID 26424652, PMID 27269947, PMID 28911074, PMID 29920566, PMID 33242451, PMID 37781191